News
A new study published in Diabetes Technology and Therapeutics showed that one of the main causes of postprandial and ...
Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have type 1 diabetes. Regulatory submissions are expected in 2026, and if ...
The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with diabetes.
I’m an old dog. There’s no denying it. I like to do things the way I have always done them. But I also like to keep current ...
Afon Technology has been a leader in diabetes innovation with its GlucowearTM device, the world’s first non-invasive glucose ...
Scientists have identified a simple, noninvasive method for assessing blood glucose regulation using continuous glucose monitoring (CGM) data. Their approach, which tracks glucose fluctuations, ...
Discover 7 practical, research-backed methods to dramatically lower your diabetes risk and protect your long-term health ...
Blueberries offer many health benefits, including antioxidants, polyphenols, and more. Here, one editor shares what happened ...
AI technologies hold immense potential to transform diabetes self-care by improving monitoring, enabling personalized ...
The highs and lows of blood glucose aren't just an energy rollercoaster; they could be a key to detecting diabetes risk early and spare you a needle prick or two.
A novel approach utilizing continuous glucose monitoring (CGM) detects early signs of impaired glucose regulation in individuals without a prior diabetes diagnosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results